MIR SCIENTIFIC
Company Snapshot
Founded: 2013
Entity Type: Private
Region: U.S.
Headquarter: New York, U.S.
Key Geographics: U.S.
Corporate Address: 7 World Trade Center 250 Greenwich Street, Flr 46 New York, New York 10007 U.S. Tel. +1 www.mirscientific.com
Company Overview
miR Scientific, LLC is a molecular diagnostic company. It is a majority-owned operating subsidiary of Huminn Inc. (formally known as Impact NRS), headquartered in New York, with operating subsidiaries in Israel, Canada, and Puerto Rico. miR Scientific has developed the miR Disease Management Platform, a proprietary, non-invasive platform for effectively managing targeted diseases, initially focused on urological cancers, including prostate, bladder, and other urothelial cancers.
Company's Business Segments
- Products and Services : The company generates revenue by offering products and services such as the miR Disease Management Platform and Molecular Diagnostic Prostate Cancer Testing.
Applications/End User Industries
- Molecular Diagnostics
- Healthcare
BCC Research Beacon 